Algorhythm (NASDAQ:RIME – Get Free Report) was upgraded by equities research analysts at Zacks Research to a “hold” rating in a research note issued to investors on Tuesday,Zacks.com reports. Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Algorhythm in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $5.00. Algorhythm (NASDAQ:RIME – Get Free Report) last issued its quarterly earnings results on Wednesday, November 19th.